Pharmacogenomic and Genetic Testing Solutions
Cygenex offers a comprehensive portfolio of clinical (require a physician's prescription) and non-clinical genetic tests designed to help you make better and smarter healthcare decisions.
Our Pharmacogenomic (PGx) testing provides meaningful data about your reaction to medications and can help reduce adverse drug events and identify more appropriate medicines or doses, often at a lower cost.
Discover your heart’s needs through your DNA testing. Your DNA can tell you a lot about your heart, including your risks of various heart-related health conditions, effective diets, and heart medication response.
The Diabetes-Obesity Panel examines 56 genes associated with Diabetes and obesity. Patients identified with a disease-causing change in a gene may benefit from increased surveillance, targeted and personalized management, and preventative steps to better manage their risk.
The Parkinson’s, Alzheimer’s, and Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson's disease, Alzheimer's disease, and genetic disorders that cause dementia.
CGX Comprehensive Cancer
The Full Comprehensive Cancer Panel examines 44 genes associated with hereditary cancer. This panel includes both well-established genes that increase a person’s risk for cancer.